Answers are grounded in this paper and cite their sources.
Research shows oncogenic effects of LINC01106 in OSCC, suggesting its potential as a therapeutic target.
LINC01106 exerts oncogenic effects via the miR-449a/MYC axis and may serve as a therapeutic target in OSCC.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: